Professor Roger Patient is currently a Visiting Professor in Oxford, having been Professor of Developmental Genetics for 14 years. Previously he was Professor of Molecular Genetics and Director of the Developmental Biology Research Centre at King’s College London, and Professor of Genetics at Nottingham University. He was also Deputy Director of the MRC Molecular Haematology Unit at the Weatherall Institute of Molecular Medicine in Oxford. Roger’s research interests include defining the transcriptional networks that programme haematopoietic stem cells during embryonic development, and the embryonic signalling pathways that lay these programmes down. A similar approach to development of the myocardium has been taken and used to understand cardiac regeneration in zebrafish. Roger has served on several MRC and medical charity panels, as Deputy Chair of the MRC Molecular and Cellular Medicine Board and as a member of the British Heart Foundation Chairs and Programme Grants Committee. He is an elected member of EMBO and recently received a Royal Society/Wolfson Merit Award. Roger is a co-founding principal investigator of OxStem Cardio.
Robin Choudhury is Professor of Cardiovascular Medicine at the University of Oxford; Hon. Consultant Cardiologist at the John Radcliffe Hospital; Clinical Director of the Oxford Acute Vascular Imaging Centre and Research Fellow in Biomedical Sciences at Balliol College. His research interests focus on: (1) Development and application of imaging techniques for the characterization of atherosclerosis, thrombosis and myocardial injury and in particular on the development of molecular imaging approaches & (2) Understanding the role of monocytes and macrophages in acute MI, myocardial regeneration and atherosclerosis and how these cells are 'programmed' through by genetic / epigenetic and metabolic mechanisms. Robin is PI of the NovoNordisk Foundation Tripartite Immuno-metabolism Consortium (TrIC). He serves on the Editorial Board of the Journal of the American Journal of Cardiology (Section Editor, Clinical Cardiology).
Professor Paul Riley is Chair of Development and Cell Biology in the Department of Physiology, Anatomy and Genetics at the University of Oxford, having been awarded a British Heart Foundation Personal Chair of Regenerative Medicine grant to support this position. He is also director of the BHF Oxbridge Centre for Regenerative Medicine. Paul was previously Professor of Molecular Cardiology at the UCL-Institute of Child Health, London, where he was a principal investigator within the Molecular Medicine Unit at UCL-ICH since 1999. Prior to this, he obtained his PhD at UCL and completed post-doctoral fellowships at the Samuel Lunenfeld Research Institute, Toronto, and the Weatherall Institute of Molecular Medicine, Oxford. In 2008, Professor Riley was awarded the Outstanding Achievement Award of the European Society of Cardiology (ESC) Council on Basic Sciences. The award recognises a landmark discovery in the field of basic cardiovascular science when his team found that Thymosin b4 could mobilise dormant cells from adult epicardium to form new blood vessels in the heart, a major step towards finding a DIY mechanism to repair injury following a heart attack. Currently Professor Riley's research is focused on exploiting the full potential of activated epicardial cells towards regenerating adult heart and understanding the mechanisms of activation of this lineage to extrapolate to human patients suffering from cardiovascular disease. Paul is a co-founding principal investigator of OxStem Cardio.